A Kazmierczak
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria 22
- Endocrinology top 5%
-
- Antibiotic Use and Resistance 6
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy 21
- Microbiology top 10%
- Bacterial Infections and Vaccines 5
-
- Pneumonia and Respiratory Infections 9
-
- Antimicrobial Resistance in Staphylococcus 5
-
- Blood disorders and treatments 4
-
- Bacterial Identification and Susceptibility Testing 4
- Co-authors
- A. PéchinotEliane SiéborH. PortierCatherine NeuwirthJosefa López MarínJean-Marie DuezP. ChavanetPierre Pothier
- Journals
- Journal of Clinical Microbiology (2 papers)The Journal of Infectious Diseases (1 paper)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- FranceSwitzerland
In The Last Decade
A Kazmierczak
43 papers receiving 422 citations
Peers
Comparison fields: 5 of 59
- Molecular Medicine 230
- Endocrinology 79
- Applied Microbiology and Biotechnology 28
- Pharmacology 179
- Microbiology 60
Countries citing papers authored by A Kazmierczak
This map shows the geographic impact of A Kazmierczak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Kazmierczak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Kazmierczak more than expected).
Fields of papers citing papers by A Kazmierczak
This network shows the impact of papers produced by A Kazmierczak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Kazmierczak. The network helps show where A Kazmierczak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Kazmierczak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [A three-dimensional model for in vitro study of the association of three antibiotics. Application to the activity of piperacillin, tazobactam and amikacin against five strains of enterobacteria as a function of their phenotype of beta-lactam resistance]. | 1998 | 1 |
| 2 | 1997 | 1 | |
| 3 | 1996 | 10 | |
| 4 | [In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin]. | 1995 | 2 |
| 5 | [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]. | 1994 | 1 |
| 6 | 1992 | 19 | |
| 7 | 1990 | 16 | |
| 8 | 1989 | 11 | |
| 9 | [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus]. | 1989 | 6 |
| 10 | 1989 | 2 | |
| 11 | 1985 | 9 | |
| 12 | 1985 | 14 | |
| 13 | 1984 | 38 | |
| 14 | [HPLC study of the inhibition of enterobacterial cephalosporinases by cefmenoxime]. | 1984 | 1 |
| 15 | 1984 | 7 | |
| 16 | [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)]. | 1981 | 2 |
| 17 | 1980 | 14 | |
| 18 | [Treatment of experimental brucellosis of mice and guinea pigs by rifampicin]. | 1976 | 2 |
| 19 | [Rifampicin and tetracycline in the treatment of experimental brucellosis in mice]. | 1972 | 2 |
| 20 | 1971 | 3 |
About A Kazmierczak
A Kazmierczak is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 47 papers that have together received 477 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Use and Resistance (6 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Infections and Vaccines (5 papers), Blood disorders and treatments (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). The work is most often cited by research in Molecular Medicine (230 citations), Endocrinology (79 citations) and Applied Microbiology and Biotechnology (28 citations). A Kazmierczak has collaborated with scholars based in France and Switzerland. Frequent co-authors include A. Péchinot, Eliane Siébor, H. Portier, Catherine Neuwirth, Josefa López Marín, Jean-Marie Duez, P. Chavanet, Pierre Pothier, Roger Labia and Jean‐Bernard Gouyon. Their work appears in journals such as Journal of Clinical Microbiology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.